Neuroimmune Interactions May Help Explain Inflammatory Pain, Lead to Better Treatments

Researchers have just taken the most fine-grained look to date at inflammatory pain: increased sensitivity to pain that follows an immune response to a wound, infection, sunburn, arthritis, or other trigger.

In mouse and computer model experiments, the team identified thousands of molecular interactions—most not previously known—between pain-initiating neurons, or nociceptors, and different types of immune cells. These interactions could help explain why pain hypersensitivity sometimes occurs during inflammation—and could also help researchers resolve it.

Results are published in Nature Immunology.

The findings provide a platform to advance understanding of pain and find better treatments. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are the current go-to for inflammatory pain, and while these medicines work fairly well, chronic use can cause side effects, and they aren't equally effective for all sources of pain.

Study senior author Clifford Woolf, Harvard Medical School professor of neurology and neurobiology and director of the F.M. Kirby Neurobiology Center at Boston Children's Hospital, has been trying to identify safer, more effective painkillers that don't involve opioids. The new study—led by first author Aakanksha Jain, HMS research fellow in neurology at Boston Children's, in collaboration with the HMS Laboratory of Systems Pharmacology as part of the STOP PAIN program—takes another step toward that goal.

Neuroimmune interactions

Jain and colleagues used single-cell RNA sequencing to explore the crosstalk between nociceptors and different types of immune cells in the skin when mice were exposed to three different types of pain triggers.

Each trigger produced extensive changes in gene expression in the different immune cell types, especially macrophages. Some changes happened right away while others took days to appear.

Next, using a database of neuroimmune interactions generated through a platform called INDRA, Jain and colleagues mapped out separate cellular "interactomes" for each injury type before, during, and after a pain episode.

Cell signaling went in both directions: Immune cells acted on nociceptors and vice versa.

"In the past, people looked at the nervous system's role in pain and the immune system's role in pain," said Woolf. "We're saying that's an artificial separation; the immune and nervous system work together. We have to embrace complexity."

The key finding was that inflammatory pain isn't a single entity. Each of the three inflammatory pain sources the researchers tested produced distinct networks of interactions between nociceptors and immune cells. That means all three have different mechanisms driving pain, said Jain.

Jain added that understanding the fundamentals of inflammatory pain provides a more solid foundation for finding ways to quell it.

"Now that we have the network of interactions, we can look for ways to promote resolution of pain," she said.